معرفی
Dr. Anish Sharda is an Assistant Professor of Medicine at Yale School of Medicine, specializing in classical hematology with clinical focus on bleeding, clotting, and platelet disorders. His NIH-funded research explores von Willebrand disease and vascular biology mechanisms.
Education:
- MBBS (Medical Degree), B.P. Koirala Institute of Health Sciences, Nepal (200X)
- Residency in Internal Medicine, University of Minnesota Medical Center (2011)
- Fellowship in Hematology/Oncology, Beth Israel Deaconess Medical Center & Harvard Medical School (2014)
Research Interests: Dr. Sharda’s work spans thrombosis, platelet biology, and vascular disorders. His lab investigates molecular regulators of von Willebrand factor maturation and novel treatments for bleeding disorders. Key projects include cryo-EM studies of platelet transporters (ABCC4) and antithrombotic drug mechanisms.
Key Publications: Recent studies include insights into platelet pharmacology via cryo-EM, aspirin prophylaxis in joint surgery, and protein isomerases in thrombus formation. His work bridges basic science and clinical applications in hematology.
Awards:
- JH Milstone Fund (2023)
- Forget Scholar (2022)
- Young Investigator Awards (2010-2013)
Advising & Grants: NIH grants support his lab’s research. Collaborates with institutions such as Beth Israel Deaconess Medical Center and Harvard Medical School. Active in clinical trials for anticoagulant therapies.
Labs/Teams: Member of the Vascular Biology and Therapeutics Program, Smilow Cancer Hospital’s Hematology program, and Yale Cancer Center. Leads interdisciplinary projects in translational hematology.